i
Analysis of severe adverse events reported among patients receiving isoniazid-rifapentine treatment for latent Mycobacterium tuberculosis infection — United States, 2012–2016
-
12 03 2020
-
-
Source: Clin Infect Dis. 71(9):2502-2505
Details:
-
Alternative Title:Clin Infect Dis
-
Personal Author:
-
Description:We analyzed data from 2012 to 2016 for patients who were hospitalized or who died after ≥1 dose of isoniazid-rifapentine for treatment of latent Mycobacterium tuberculosis infection. No patients died; 15 were hospitalized. Nine patients experienced hypotension, and 5 had elevated serum aminotransferases, reinforcing the need for vigilant monitoring during treatment.
-
Subjects:
-
Source:
-
Pubmed ID:32185390
-
Pubmed Central ID:PMC8020883
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: